• The first innovative drug to be developed in Israel and to receive FDA approval, Copaxone® is a unique multiple sclerosis immunomodulator: the first and only non-interferon agent for the treatment...

    Read more
  • (Beta-carotene), a health food product with possible anti-cancer properties, extracted from Dunaliella, a local alga, licensed to Nikken Sohonsha...

    Read more
  • DayTwo provides personalized nutrition and actionable insights that allow consumers to live healthier and maintain normal blood sugar levels. DayTwo does this through DNA sequencing of the gut...

    Read more
  • Yeda, the technology transfer arm of the Weizmann Institute of Science, has signed a license agreement with ’3i.’ Other microscopy systems based on Weizmann research are being sold by ‘Idea Bio-...

    Read more
  • ,

    STEBA Biotech is a privately owned biotechnology company headquartered in Luxembourg with offices in France, Israel, Switzerland, and the US.  
    Steba Biotech’s flagship product, TOOKAD®, for...

    Read more
  • ImmunArray, developer of the iCHIP™, a groundbreaking in-vitro auto-antibody profiling platform is pleased to announce the launch of their first commercial diagnostic product, SLE-key™ Rule Out,...

    Read more
  • ,

    WiScan® Hermes is a High content screening Fluorescence and Bright Field scanning system which operates at extremely high speeds of image acquisition, and generates exceptionally high quality...

    Read more
  • Vitamin Alpha D3 is a molecule discovered by Institute researchers and produced under license by Teva Pharmaceuticals Ltd. for the treatment of osteoporosis and bone decalcification.

    ...

    Read more
  • Centre Hospitalier Universitaire (CHU) d'Angers in France is conducting a clinical trial of RP103 called "CYST-HD Multicentre study of treatment of Huntington’s Disease with cysteamine, a...

    Read more
  • ,

    (Recombinant interferon beta), identical to the native molecule and registered for the treatment of multiple sclerosis and several viral diseases, licensed to Inter-Lab Ltd., a Serono company.  ...

    Read more
  • NanoLubTM, is the world’s first commercial solid lubricant based on spherical inorganic nanoparticles. NanoLubTM reduces friction & wear significantly better than conventional lubricants....

    Read more
  • GeneCards® is a searchable, integrated database of human genes that provides concise genomic related information, on all known and predicted human genes

    The GeneCards human gene database...

    Read more
  • Kibbutz Dorot is the largest producer of garlic in Israel.

    Following research conducted at the Weizmann Institute of Science, Kibbutz Dorot has developed a garlic capsule – a revolutionary...

    Read more
  • Native interferon beta), licensed to Inter-Lab Ltd., a Serono company, and used as an antiviral and anti-cancer drug, with sales exceeding 40$ million annually, until replaced by Rebif®.

  • An antibody based therapy presenting synergism with conventional chemotherapy. The synergistic effect was invented at the Weizmann Institute. Erbitux was developed by ImClone Systems and approved...

    Read more
  • A recombinant hepatitis B vaccine that integrates the S, pre-S1, and pre-S2 surface proteins of the hepatitis B virus. Enables successful immunization with significantly lower doses of vaccine...

    Read more